Korro amended its research collaboration and license agreement with Novo Nordisk A/S (Novo Nordisk). This amendment establishes a 12-month pause to reassess the rationale for the current target under ...

Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs, and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life ...

Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

Nearly 20 million people die every year from cardiovascular diseases, the leading cause of death worldwide. Genetic and ...

PRINCETON, N.J., Nov. 4, 2025 /PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

A metagenomic study uncovers how gut bacteria influence coronary artery disease, showing a loss of protective species and ...

New research reveals how gut microbes may influence the development of coronary artery disease, the world’s leading killer.

Gut microbes likely play a role in coronary artery disease (CAD), a common heart disease, but the mechanisms remain largely unknown. Researchers in Seoul recently identified 15 bacterial species ...

Our high-resolution metagenomic map shows a dramatic functional shift toward inflammation and metabolic imbalance, a loss of ...

When we get sick, with the flu, say, or pneumonia, there can be a period where the major symptoms of our illness have ...

Europe's space agency is pioneering a groundbreaking project, HOBI-WAN, to generate protein from gases like hydrogen and ...